Limited HIV-1 Subtype C
3′-polypurine tract
Botswana
HIV-1
dolutegravir
drug resistance mutations
nef
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
13 Aug 2021
13 Aug 2021
Historique:
received:
28
05
2021
revised:
05
08
2021
accepted:
11
08
2021
entrez:
28
8
2021
pubmed:
29
8
2021
medline:
29
8
2021
Statut:
epublish
Résumé
Dolutegravir (DTG) is a potent anti-HIV drug that is used to treat HIV globally. There have been reports of mutations in the HIV-1 3'-polypurine tract (3'PPT) of the
Identifiants
pubmed: 34451492
pii: pathogens10081027
doi: 10.3390/pathogens10081027
pmc: PMC8400509
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : FIC NIH HHS
ID : D43TW010543
Pays : United States
Organisme : NIH HHS
ID : NIH K24 AI131928
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI131928
Pays : United States
Organisme : Wellcome Trust
ID : DEL-15-006
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : D43 TW009610
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001911
Pays : United States
Organisme : CGH CDC HHS
ID : U01 GH000447
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States
Références
Nat Med. 1996 Mar;2(3):338-42
pubmed: 8612235
J Virol. 2020 Feb 14;94(5):
pubmed: 31776273
Lancet HIV. 2016 May;3(5):e221-30
pubmed: 27126489
Retrovirology. 2013 Oct 30;10:125
pubmed: 24172637
Int J Mol Sci. 2020 Feb 25;21(5):
pubmed: 32106437
PLoS One. 2019 Nov 21;14(11):e0224292
pubmed: 31751353
Retrovirology. 2017 Jun 5;14(1):36
pubmed: 28583191
J Antimicrob Chemother. 2019 Dec 1;74(12):3440-3444
pubmed: 31730161
J Virol. 1994 May;68(5):3092-101
pubmed: 8151774
Bioinformatics. 2019 May 15;35(10):1763-1765
pubmed: 30295730
Retrovirology. 2018 Aug 17;15(1):56
pubmed: 30119633
N Engl J Med. 2019 Jul 18;381(3):230-242
pubmed: 31314967
J Virol. 2004 Dec;78(23):13315-24
pubmed: 15542682
Virology. 2007 Apr 10;360(2):341-9
pubmed: 17123564
mBio. 2018 Apr 10;9(2):
pubmed: 29636435
J Infect Dis. 2018 Jul 24;218(5):688-697
pubmed: 29617822
Nature. 1991 Apr 11;350(6318):508-11
pubmed: 2014052
Antimicrob Agents Chemother. 2021 May 18;65(6):
pubmed: 33722887
mBio. 2017 Sep 26;8(5):
pubmed: 28951475
Viruses. 2021 Mar 31;13(4):
pubmed: 33807382
Lancet. 2013 Mar 2;381(9868):735-43
pubmed: 23306000